Aimei Health Technology (NASDAQ:AFJK) Stock Price Breaks Above 50-Day Moving Average – Here’s Why

Aimei Health Technology Co., Ltd. (NASDAQ:AFJK) passed above its 50-day moving average during trading on Tuesday. The stock has a 50-day moving average of $12.22 and traded as high as $12.75. Aimei Health Technology shares last traded at $12.43, with a volume of 10,748 shares traded.

Analyst Ratings Changes

AFJK has been the topic of several recent analyst reports. Wall Street Zen upgraded Aimei Health Technology to a “sell” rating in a research note on Saturday, September 19th. Weiss Ratings downgraded Aimei Health Technology from a “sell (d+)” rating to a “sell (d)” rating in a report on Friday, August 21st. One investment analyst has rated the stock with a Sell rating. Based on data from MarketBeat, the company has a consensus rating of “Sell”.

Aimei Health Technology Stock Performance

The business’s fifty day moving average price is $12.22 and its 200-day moving average price is $26.59. The stock has a market cap of $39.40 million, a PE ratio of 207.20 and a beta of 0.97.

Aimei Health Technology (NASDAQ:AFJK) last released its quarterly earnings data on Thursday, August 13th. The company reported ($0.03) earnings per share for the quarter.

Hedge Funds Weigh In On Aimei Health Technology

A hedge fund recently bought a new position in Aimei Health Technology stock. First Trust Capital Management L.P. purchased a new position in Aimei Health Technology Co., Ltd. (NASDAQ:AFJK) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 677,008 shares of the company’s stock, valued at approximately $8,199,000. First Trust Capital Management L.P. owned about 21.38% of Aimei Health Technology at the end of the most recent reporting period. Institutional investors and hedge funds own 45.58% of the company’s stock.

About Aimei Health Technology

Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.